{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T14:52:24Z","timestamp":1776091944917,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology of Taiwan","doi-asserted-by":"publisher","award":["V105B-001"],"award-info":[{"award-number":["V105B-001"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology of Taiwan","doi-asserted-by":"publisher","award":["V106B-001"],"award-info":[{"award-number":["V106B-001"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Szu-Yuan Research Foundation of Internal Medicine","award":["106005"],"award-info":[{"award-number":["106005"]}]}],"content-domain":{"domain":["clinicalkey.jp","ijaaonline.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.ijantimicag.2017.05.018","type":"journal-article","created":{"date-parts":[[2017,6,28]],"date-time":"2017-06-28T13:47:48Z","timestamp":1498657668000},"page":"47-51","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Comparison of the therapeutic efficacy of fluoroquinolone and non-fluoroquinolone treatment in patients with Elizabethkingia meningoseptica bacteraemia"],"prefix":"10.1016","volume":"51","author":[{"given":"Ying-Chi","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Tsung","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fu-Der","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2017.05.018_bib0010","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1099\/ijs.0.63541-0","article-title":"Transfer of Chryseobacterium meningosepticum and Chryseobacterium miricola to Elizabethkingia gen. nov. as Elizabethkingia meningoseptica comb. nov. and Elizabethkingia miricola comb. nov","volume":"55","author":"Kim","year":"2005","journal-title":"Int J Syst Evol Microbiol"},{"key":"10.1016\/j.ijantimicag.2017.05.018_bib0015","doi-asserted-by":"crossref","first-page":"481","DOI":"10.3201\/eid0605.000506","article-title":"Atypical Chryseobacterium meningosepticum and meningitis and sepsis in newborns and the immunocompromised, Taiwan","volume":"6","author":"Chiu","year":"2000","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ijantimicag.2017.05.018_bib0020","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/00005792-199701000-00003","article-title":"Cryseobacterium meningosepticum: an emerging pathogen among immunocompromised adults. Report of 6 cases and literature review","volume":"76","author":"Bloch","year":"1997","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ijantimicag.2017.05.018_bib0025","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3201\/eid2201.150139","article-title":"Waterborne Elizabethkingia meningoseptica in adult critical care","volume":"22","author":"Moore","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ijantimicag.2017.05.018_bib0030","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jhin.2013.05.012","article-title":"Bad design, bad practices, bad bugs: frustrations in controlling an outbreak of Elizabethkingia meningoseptica in intensive care units","volume":"85","author":"Balm","year":"2013","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.ijantimicag.2017.05.018_bib0035","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1080\/00365540903089476","article-title":"Clinical and microbiological analysis of Elizabethkingia meningoseptica bacteremia in adult patients in Taiwan","volume":"41","author":"Lin","year":"2009","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2017.05.018_bib0040","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1007\/s10096-011-1223-0","article-title":"Clinical features, antimicrobial susceptibilities, and outcomes of Elizabethkingia meningoseptica (Chryseobacterium meningosepticum) bacteremia at a medical center in Taiwan, 1999\u20132006","volume":"30","author":"Hsu","year":"2011","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2017.05.018_bib0045","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.jhin.2014.01.009","article-title":"Elizabethkingia meningoseptica: an important emerging pathogen causing healthcare-associated infections","volume":"86","author":"Jean","year":"2014","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.ijantimicag.2017.05.018_bib0050","first-page":"137","article-title":"Chryseobacterium meningosepticum infection: antibiotic susceptibility and risk factors for mortality","volume":"41","author":"Hung","year":"2008","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.ijantimicag.2017.05.018_bib0055","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.ijantimicag.2010.06.033","article-title":"Biofilm production, use of intravascular indwelling catheters and inappropriate antimicrobial therapy as predictors of fatality in Chryseobacterium meningosepticum bacteraemia","volume":"36","author":"Lin","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2017.05.018_bib0060","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1128\/JCM.42.1.445-448.2004","article-title":"Antimicrobial susceptibility and epidemiology of a worldwide collection of Chryseobacterium spp.: report from the SENTRY Antimicrobial Surveillance Program (1997\u20132001)","volume":"42","author":"Kirby","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2017.05.018_bib0065","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ijantimicag.2004.10.002","article-title":"Antimicrobial susceptibility of uncommonly isolated non-enteric Gram-negative bacilli","volume":"25","author":"Sader","year":"2005","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2017.05.018_bib0070","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1128\/AAC.01324-13","article-title":"Monotherapy with fluoroquinolone or trimethoprim-sulfamethoxazole for treatment of Stenotrophomonas maltophilia infections","volume":"58","author":"Wang","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2017.05.018_bib0075","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1128\/AAC.01682-13","article-title":"Can levofloxacin be a useful alternative to trimethoprim-sulfamethoxazole for treating Stenotrophomonas maltophilia bacteremia?","volume":"58","author":"Cho","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2017.05.018_bib0080","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.2169\/internalmedicine.54.4998","article-title":"A nephrostomy-associated urinary tract infection caused by Elizabethkingia meningoseptica","volume":"54","author":"Hagiya","year":"2015","journal-title":"Intern Med"},{"key":"10.1016\/j.ijantimicag.2017.05.018_bib0085","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S1726-4901(08)70151-5","article-title":"Chryseobacterium meningosepticum sepsis complicated with retroperitoneal hematoma and pleural effusion in a diabetic patient","volume":"71","author":"Lee","year":"2008","journal-title":"J Chin Med Assoc"},{"key":"10.1016\/j.ijantimicag.2017.05.018_bib0090","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.diagmicrobio.2007.07.009","article-title":"Community-acquired osteomyelitis caused by Chryseobacterium meningosepticum: case report and literature review","volume":"60","author":"Lee","year":"2008","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2017.05.018_bib0095","doi-asserted-by":"crossref","first-page":"791","DOI":"10.7326\/0003-4819-137-10-200211190-00007","article-title":"Health care\u2013associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections","volume":"137","author":"Friedman","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ijantimicag.2017.05.018_bib0100","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jinf.2011.11.005","article-title":"Characteristics of healthcare-associated and community-acquired Klebsiella pneumoniae bacteremia in Taiwan","volume":"64","author":"Wu","year":"2012","journal-title":"J Infect"},{"key":"10.1016\/j.ijantimicag.2017.05.018_bib0105","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/cid\/cir805","article-title":"High-dose daptomycin for cardiac implantable electronic device-related infective endocarditis","volume":"54","author":"Durante-Mangoni","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2017.05.018_bib0110","series-title":"Clinical and Laboratory Standards Institute: performance standards for antimicrobial susceptibility testing: twenty-fourth informational supplement","author":"Wayne","year":"2012"},{"key":"10.1016\/j.ijantimicag.2017.05.018_bib0115","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s13054-016-1285-6","article-title":"Advances in antibiotic therapy in the critically ill","volume":"20","author":"Vincent","year":"2016","journal-title":"Crit Care"},{"key":"10.1016\/j.ijantimicag.2017.05.018_bib0120","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.addr.2014.07.006","article-title":"The effect of pathophysiology on pharmacokinetics in the critically ill patient\u2013concepts appraised by the example of antimicrobial agents","volume":"77","author":"Blot","year":"2014","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.ijantimicag.2017.05.018_bib0125","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1093\/jac\/dks053","article-title":"Use of therapeutic drug monitoring to treat Elizabethkingia meningoseptica meningitis and bacteraemia in an adult","volume":"67","author":"Neuner","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2017.05.018_bib0130","doi-asserted-by":"crossref","first-page":"881","DOI":"10.7326\/0003-4819-100-6-881","article-title":"Trimethoprim-sulfamethoxazole for bacterial meningitis","volume":"100","author":"Levitz","year":"1984","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ijantimicag.2017.05.018_bib0135","doi-asserted-by":"crossref","first-page":"e37375","DOI":"10.1371\/journal.pone.0037375","article-title":"Stenotrophomonas maltophilia infections in a general hospital: patient characteristics, antimicrobial susceptibility, and treatment outcome","volume":"7","author":"Samonis","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ijantimicag.2017.05.018_bib0140","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1093\/jac\/dkv456","article-title":"Monotherapy with minocycline or trimethoprim\/sulfamethoxazole for treatment of Stenotrophomonas maltophilia infections","volume":"71","author":"Hand","year":"2016","journal-title":"J Antimicrob Chemother"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857917302352?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857917302352?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,31]],"date-time":"2018-08-31T09:28:35Z","timestamp":1535707715000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857917302352"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S0924857917302352"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2017.05.018","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of the therapeutic efficacy of fluoroquinolone and non-fluoroquinolone treatment in patients with Elizabethkingia meningoseptica bacteraemia","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2017.05.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}